Results 91 to 100 of about 103,354 (261)

Managing Terminal Illness

Journal of the Royal College of Physicians of London, 1996
K, Forbes, C, Davis
openaire   +2 more sources

Hope in the terminally ill

Western Journal of Medicine, 2000
The diagnosis of a terminal illness initially precipitates a vulnerability and isolation that belie description as contemplation of one's impending death transcends the mundane activities of daily living. Mortality is suddenly confronted, and the concept of hope wanes as the unattainable goal of extended life vanishes.
openaire   +3 more sources

Analysis of Single Particles of Amyloid Beta and α‐Synuclein With Seeded Amplification for the Diagnosis of Alzheimer's and Parkinson's Disease

Biotechnology and Applied Biochemistry, EarlyView.
ABSTRACT Neurodegenerative diseases, including Alzheimer's disease (AD) and Parkinson's disease (PD), are characterized by the pathological aggregation of specific proteins such as amyloid beta (Aβ) and α‐synuclein, respectively. Early detection of these protein aggregates in biological fluids could facilitate timely diagnosis and therapeutic ...
Alexandra Dybala, Marlene Pils, Oliver Bannach, Gültekin Tamgüney, Detlev Riesner   +4 more
wiley   +1 more source

Is a terminally ill non-cancer patient really forced to stay at the hospital?

Italian Journal of Medicine
Dear Editor, for many years the National Health Service has taken care of terminal illness in its clinical, ethical, and legal aspects...
Francesco Serafini, Maria Gabriella Procacci, Elia Vettore, Giulia Cardinali, Fabio Presotto   +4 more
doaj   +1 more source

Paediatric development of radiopharmaceutical imaging agents and radioligand therapeutics

British Journal of Clinical Pharmacology, EarlyView.
Abstract This review focuses on the development of radiopharmaceutical imaging agents and radioligand therapeutics for paediatric use. Nuclear medicine plays an important role in the diagnosis and treatment of various childhood conditions, including cancers, infections and brain disorders.
Justin L. Hay, Amandine Manon, Hunter Stephens, S. Y. Amy Cheung, Bart de Keizer, Erik T. te Beek   +5 more
wiley   +1 more source

Addressing Death Anxiety in Terminally III Patients: A Review of Current Interventions and Future Directions

Frontiers on Healthcare Research
particularly those facing chronic or terminal illnesses. Understanding the factors influencing death anxiety and the effectiveness of interventions is crucial for improving patient care and outcomes. This review aims to explore the psychological, social,
Defia Roza, Heppi Sasmita, Yessi Fadriyanti   +2 more
doaj  

Clinical pharmacology and prescribing education: An updated medical school curriculum from the British Pharmacological Society

British Journal of Clinical Pharmacology, EarlyView.
Aims Prescribing is a complex, essential skill that doctors must acquire to practice medicine safely and effectively. The British Pharmacological Society has historically provided a core curriculum to guide clinical pharmacology and prescribing education in UK medical schools.
Dagan O. Lonsdale, Clare Guilding, Jennifer Koenig, Michael Okorie, Reecha Sofat, Simon Maxwell   +5 more
wiley   +1 more source

When Breath Becomes Air: Constructing Stable Narrative Identity during Terminal Illness

Colloquy: Text, Theory, Critique, 2019
This article tackles the question of how narrative identity can be shaped and stabilised during terminal illness. It focuses on how the experience of cancer challenges, or possibly strengthens, the sense of identity by sharing narratives of the past, by ...
Deborah de Muijnck
doaj   +1 more source

Cannabinoids and drug–drug pharmacokinetic interactions: Deciphering the risks

British Journal of Clinical Pharmacology, EarlyView.
The relationship between cannabinoids and mental health has become a major focus of scientific inquiry and public discourse. Cannabinoids are diverse chemical compounds from the Cannabis species that have been explored for their therapeutic applications in treating chronic pain, psychiatric and neurological conditions, such as depression, schizophrenia,
Paraskevi Papakyriakopoulou, Georgia Valsami, Georgios Ismailos   +2 more
wiley   +1 more source

Efficacy, safety and cost‐effectiveness of CAR‐T therapy

British Journal of Clinical Pharmacology, EarlyView.
CAR T‐cells demonstrate high efficacy in blood cancers, including ALL, MM and DLBCL. Innovations target solid tumours despite challenges such as antigen escape. Combination therapies enhance the delivery and infiltration of CAR T cells. Toxicity, cost and resistance remain major barriers to clinical use.
Emina Karahmet Sher, Amina Džidić‐Krivić, Emma Pinjic, Nejra Selak, Kanita Omerbasic, Alexandar Chupin, Andrej Belancic, Almir Fajkic   +7 more
wiley   +1 more source